Skip to main content
OpenTrials
Completed

NCT Number: NCT02486913

Enhancing Diagnosis and Prevention of Cardiovascular Disease in Newham by Integrated Use of Electronic Health Records

The investigators will develop a "risk report" within the primary care electronic health record (EMIS) for patients attending for their National Health Service Health Check. The value of the report for reducing cardiovascular risk will be assessed qualitatively and also quantitatively in a non-randomised comparative trial.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–74 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bart's Heart Centre

London, E1A 7BE, United Kingdom

About this study

The investigators will design a template within the primary care electronic health record (EMIS) that draws on Health Check data to provide a contemporary "risk report". Included in the report will be clear description of life-time cardiovascular risks, the factors driving those risks and how risk might be reduced through life-style and risk factor modification. The investigators will evaluate the benefits of providing patients with a risk report qualitatively by patient and clinician interviews. Quantitative analysis of the benefit of the risk report will be provided by a non-randomised comparative trial. First, a group of patients undergoing a conventional Health Check will be recalled after three months for a second Health Check, allowing measurement of the change in "Heart Age" - a convenient index of life-time cardiovascular risk. Following introduction of the risk report the investigators will recall a further group of patients for a second Health Check, allowing measurement of the change in "Heart Age". The effect of the risk report will be determined by comparing the change in Heart Age between the two groups of patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 40-74 years

Exclusion criteria

  • Prior diagnosis of heart disease, stroke, diabetes, kidney disease or dementia

Treatment and study plan

Enhanced Health Check

Other

National Health Service Health Check enhanced by risk report

Primary outcomes

  1. Change in Heart Age

    Time frame: 3 months

    Change in Heart Age between 1st Health Check and 2nd Health Check three months later

Secondary outcomes

  1. Changes in smoking status

    Time frame: 3 months

    Changes in smoking status (number smoked per day) by direct patient enquiry between 1st Health Check and 2nd Health Check three months later.

  2. Change in total cholesterol

    Time frame: 3 months

    Changes in total blood cholesterol (mmol/L) by serum sampling between 1st Health Check and 2nd Health Check three months later.

  3. Change in systolic blood pressure

    Time frame: 3 months

    Change in systolic blood pressure (mmHg) by direct measurement using an inflatable cuff between 1st Health Check and 2nd Health Check three months later.

  4. Change in body mass index

    Time frame: 3 months

    Change in body mass index by measurement of height and weight between 1st Health Check and 2nd Health Check three months later.

Sponsors and collaborators

Lead sponsor

Queen Mary University of London

Other

Registry information

Official study title

Enhancing the Diagnosis and Prevention of Cardiovascular Disease in Newham by Integrated Use of Electronic Health Records

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
Jul 1, 2015
Registry last updated
Mar 6, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.